Sangui Biotech International, Inc.
SGBI · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -52.8% | 152.2% | 40.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | 2.1% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -28.7% | 103.1% | -38.1% | 1.9% |
| EPS Diluted | -0 | 0.001 | -0 | 0 |
| % Growth | -114.3% | 800% | -3,039.8% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |